End-of-day quote
Shanghai S.E.
06:00:00 2024-05-09 pm EDT
|
5-day change
|
1st Jan Change
|
210
CNY
|
-4.21%
|
|
+5.68%
|
-35.44%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
12,456
|
36,049
|
33,284
|
33,157
|
21,399
|
-
|
-
|
Enterprise Value (EV)
1 |
12,456
|
36,049
|
31,900
|
33,258
|
18,161
|
18,762
|
19,320
|
P/E ratio
|
45.5
x
|
74.5
x
|
52
x
|
56.6
x
|
24
x
|
19.3
x
|
17.6
x
|
Yield
|
-
|
0.44%
|
0.63%
|
0.61%
|
1.24%
|
1.5%
|
1.9%
|
Capitalization / Revenue
|
15.9
x
|
30.4
x
|
21.5
x
|
17.8
x
|
8.92
x
|
7.23
x
|
6.43
x
|
EV / Revenue
|
15.9
x
|
30.4
x
|
20.6
x
|
17.8
x
|
7.57
x
|
6.34
x
|
5.8
x
|
EV / EBITDA
|
44.9
x
|
61.7
x
|
43.1
x
|
45.4
x
|
17.4
x
|
14.2
x
|
11.2
x
|
EV / FCF
|
-
|
640
x
|
-79.6
x
|
-22
x
|
-50.3
x
|
41.9
x
|
11.1
x
|
FCF Yield
|
-
|
0.16%
|
-1.26%
|
-4.54%
|
-1.99%
|
2.39%
|
8.99%
|
Price to Book
|
4.73
x
|
11.8
x
|
9.19
x
|
8.14
x
|
4.16
x
|
3.53
x
|
3.23
x
|
Nbr of stocks (in thousands)
|
101,567
|
101,567
|
101,768
|
101,941
|
101,906
|
-
|
-
|
Reference price
2 |
122.6
|
354.9
|
327.1
|
325.3
|
210.0
|
210.0
|
210.0
|
Announcement Date
|
2/23/21
|
2/24/22
|
2/23/23
|
4/19/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
784.1
|
1,187
|
1,549
|
1,864
|
2,399
|
2,960
|
3,329
|
EBITDA
1 |
277.7
|
584
|
739.9
|
732.7
|
1,046
|
1,323
|
1,718
|
EBIT
1 |
246.4
|
549.9
|
708.7
|
683.6
|
939.8
|
1,191
|
1,332
|
Operating Margin
|
31.42%
|
46.31%
|
45.75%
|
36.68%
|
39.18%
|
40.24%
|
39.99%
|
Earnings before Tax (EBT)
1 |
254.6
|
559.9
|
708.7
|
685
|
994
|
1,236
|
1,380
|
Net income
1 |
225.3
|
484
|
641.3
|
607.5
|
887
|
1,103
|
1,214
|
Net margin
|
28.73%
|
40.77%
|
41.4%
|
32.59%
|
36.98%
|
37.27%
|
36.45%
|
EPS
2 |
2.693
|
4.764
|
6.293
|
5.750
|
8.750
|
10.88
|
11.90
|
Free Cash Flow
1 |
-
|
56.36
|
-400.7
|
-1,510
|
-361
|
448
|
1,736
|
FCF margin
|
-
|
4.75%
|
-25.87%
|
-81.04%
|
-15.05%
|
15.14%
|
52.14%
|
FCF Conversion (EBITDA)
|
-
|
9.65%
|
-
|
-
|
-
|
33.87%
|
101.08%
|
FCF Conversion (Net income)
|
-
|
11.64%
|
-
|
-
|
-
|
40.61%
|
143.06%
|
Dividend per Share
2 |
-
|
1.571
|
2.071
|
2.000
|
2.607
|
3.157
|
3.980
|
Announcement Date
|
2/23/21
|
2/24/22
|
2/23/23
|
4/19/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 S1
|
2021 Q4
|
2021 S2
|
2022 S1
|
2022 Q4
|
2022 S2
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
|
-
|
363.6
|
631.7
|
-
|
445.2
|
828.5
|
-
|
-
|
-
|
-
|
466.9
|
490.9
|
-
|
-
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
|
-
|
191
|
316.2
|
-
|
146.8
|
413.3
|
-
|
-
|
-
|
-
|
204.1
|
-
|
-
|
-
|
-
|
Operating Margin
|
-
|
52.53%
|
50.05%
|
-
|
32.98%
|
49.89%
|
-
|
-
|
-
|
-
|
43.72%
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
193.8
|
324.4
|
-
|
146.7
|
413.2
|
-
|
216.2
|
364.9
|
-
|
204.5
|
154.2
|
-
|
-
|
-
|
Net income
|
209.8
|
158.2
|
274.3
|
276.4
|
133.3
|
364.9
|
-
|
187.9
|
324.6
|
-
|
174.6
|
139.3
|
-
|
-
|
-
|
Net margin
|
-
|
43.51%
|
43.42%
|
-
|
29.95%
|
44.04%
|
-
|
-
|
-
|
-
|
37.39%
|
28.37%
|
-
|
-
|
-
|
EPS
1 |
2.064
|
1.557
|
2.700
|
2.721
|
1.293
|
3.571
|
1.620
|
1.560
|
-
|
1.060
|
1.500
|
1.300
|
1.990
|
1.640
|
2.650
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
8/4/21
|
2/24/22
|
2/24/22
|
8/28/22
|
2/23/23
|
2/23/23
|
4/26/23
|
8/28/23
|
8/28/23
|
10/14/23
|
4/19/24
|
4/29/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
101
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
1,384
|
-
|
3,238
|
2,638
|
2,079
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
0.1375
x
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
56.4
|
-401
|
-1,510
|
-361
|
448
|
1,736
|
ROE (net income / shareholders' equity)
|
21.8%
|
17%
|
19.3%
|
15%
|
17.7%
|
18.6%
|
18.3%
|
ROA (Net income/ Total Assets)
|
-
|
15%
|
13.7%
|
8.3%
|
11.1%
|
12.4%
|
11.6%
|
Assets
1 |
-
|
3,228
|
4,678
|
7,315
|
8,009
|
8,932
|
10,461
|
Book Value Per Share
2 |
25.90
|
30.00
|
35.60
|
40.00
|
50.50
|
59.50
|
65.10
|
Cash Flow per Share
2 |
2.580
|
2.440
|
3.110
|
3.340
|
6.430
|
13.90
|
9.980
|
Capex
1 |
-
|
192
|
717
|
1,851
|
444
|
437
|
356
|
Capex / Sales
|
-
|
16.14%
|
46.31%
|
99.3%
|
18.49%
|
14.76%
|
10.7%
|
Announcement Date
|
2/23/21
|
2/24/22
|
2/23/23
|
4/19/24
|
-
|
-
|
-
|
Average target price
297.6
CNY Spread / Average Target +41.72% Consensus |
1st Jan change
|
Capi.
|
---|
| -35.44% | 2.96B | | -4.01% | 14.91B | | -14.59% | 2.41B | | -11.01% | 1.48B | | -.--% | 1.12B | | +58.24% | 583M | | +94.87% | 515M | | +12.77% | 244M | | +0.12% | 230M | | +4.07% | 188M |
Medical Imaging Systems
|